Search En menu en ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

Signature(s)

Amount
€ 40,000,000
Countries
Sector(s)
Denmark : € 40,000,000
Industry : € 40,000,000
Signature date(s)
10/06/2010 : € 40,000,000
Link to source
Other links

Summary sheet

Release date
24 June 2009
Status
Reference
Signed | 10/06/2010
20080780
Project name
Promoter - financial intermediary
ALK-Abello Allergy Treatment R&D
ALK-Abello A/S
Proposed EIB finance (Approximate amount)
Total cost (Approximate amount)
EUR 40 million.
EUR 97.5 million.
Location
Sector(s)
Description
Objectives

The project consists of Alk Abello's R&D activities, particularly those related to the development tablet based treatments for trees and ragweed pollen allergy, house dust mite and cat allergy and to the development of scientific models that lead to a better understanding of the immunological mechanisms of allergy and vaccination therapy, which can be used in next generation immuno-allergy vaccines. The project will be implemented in the period 2009-2010.

The project should strengthen the market position of one of the EU-based market leaders, operating in the global market for allergen immunotherapy.

Environmental aspects
Procurement

The project is expected to have no significant environmental impact.

Procurement is in line with EIB guidelines for the private sector projects.

Link to source
Other links

Disclaimer

Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

General enquiries and comments

The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
Alternatively, the EIB can be contacted through its external offices.
Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

Media enquiries

Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

Complaints mechanism

Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

Zero tolerance against fraud and corruption

The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential and handled in line with the EIB investigation procedures and the Anti-Fraud Policy.

Related publications